Baxter International Inc., BAX is in the exchange NYSE and its industry is Medical Instruments & Supplies in the sector of Healthcare. Based in USA, Baxter International Inc., BAX has a market cap of 26550.6. Since its IPO date on the 10/27/1981, Baxter International Inc., BAX performance year to date is 28.10%. Today Baxter International Inc., BAX has gained 0.48%, with a current price of 48.45.
Ownership of the company is 0.10% for insider ownership while institutional ownership is 87.20%. The management of the company have seen the company have a payout ratio of 5.40%. Return of assets are at 25.80%, with return on investment at 3.40%.
In terms of debt levels and profit levels, Baxter International Inc., BAX is seeing a long-term debt/equity of 0.25. While Total debt/equity is 0.37. With a profit margin of 47.70%, this is combined with a gross margin of 39.00%, and operating margin of -13.50%. Baxter International Inc. ability to meet debt levels, with a current ratio of 1.8, while the quick ratio is 1.4.
For the last year Baxter International Inc., BAX has seen a EPS growth of -79.90%. A performance for the year of 47.43%. The 52-week high is -1.83%, and the 52-week low is 52.00%. The average volume for Baxter International Inc., BAX is 3578900.
With a target price of 50.41, can Baxter International Inc., BAX reach this target? Looking at the value indicators of Baxter International Inc., BAX. Baxter International Inc. has a P/E of 5.59 and a forward P/E of 24.56. Perhaps the more useful indicator than P/E, is PEG which has a value of 0.43. Baxter International Inc. also has a P/S and a P/B of 2.64 and 3.12 respectively. For P/cash, Baxter International Inc. has a value of 10.1, while it is 34.08 for P/free cash flow.
At the current price of 48.45, Baxter International Inc. has a dividend yield of 1.07%. We see a return on equity of 56.10%.
Looking more long-term Baxter International Inc., is projected to get an EPS growth for the next five years of 13.00%. In the short-term an EPS growth of 14.38% in the next year is forecasted. This is after a EPS growth of -79.90% for this year and for the last five years a -21.40% growth has been seen.